Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplements and pre-eclampsia

This article was originally published in The Tan Sheet

Executive Summary

"Concomitant supplementation with vitamin C and vitamin E does not prevent pre-eclampsia in women at high risk, but does increase the rate of babies born with a low birthweight," according to a study published online by The Lancet March 30. The randomized, placebo-controlled trial enrolled 2,410 women identified as at increased risk of pre-eclampsia and who were assigned either 1,000 mg vitamin C and 400 IU vitamin E daily or placebo. Pre-eclampsia rates did not differ between the treatment group (15%) and placebo (16%), but more low birthweight babies were born to those treated than those on placebo (28% versus 4%). "As such, use of these high-dose antioxidants is not justified in pregnancy," Lucilla Poston, St. Thomas' Hospital, London, et al., conclude. "The daily doses of vitamin C and vitamin E that we gave were below the maximum recommended intake in pregnant women," they note...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel